Quince Therapeutics(QNCX.US)

Last Updated 19:00:00 ET
longbridge loading

Quince Therapeutics | 10-K: FY2025 Revenue: USD 0

Earnings Watch·
US
QNCX
-0.84%
Earnings Watch·
US
QNCX
-0.84%

Quince Therapeutics Announces 1-for-10 Reverse Stock Split

Tip Ranks·
US
IBB
+1.33%
US
PBE
+0.89%
US
BBH
+0.22%
Tip Ranks·
US
IBB
+1.33%
US
PBE
+0.89%
US
BBH
+0.22%

12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga_article·
US
ARKG
+2.70%
US
IBBQ
+1.95%
US
PBE
+0.89%
benzinga_article·
US
ARKG
+2.70%
US
IBBQ
+1.95%
US
PBE
+0.89%

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga_article·
US
IBB
+1.33%
US
ARKG
+2.70%
US
QNCX
-0.84%
benzinga_article·
US
IBB
+1.33%
US
ARKG
+2.70%
US
QNCX
-0.84%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·
US
PFSA
-1.04%
US
KPRX
+3.97%
US
CUPR
-1.42%
benzinga_article·
US
PFSA
-1.04%
US
KPRX
+3.97%
US
CUPR
-1.42%

Quince Therapeutics shares are trading higher after the company announced a settlement of its outstanding obligations under a loan from the European Investment Bank for a payment of $5.5 million.

benzinga_article·
US
BIB
+3.43%
US
SBIO
+2.21%
US
QNCX
-0.84%
benzinga_article·
US
BIB
+3.43%
US
SBIO
+2.21%
US
QNCX
-0.84%
© 2026 Longbridge｜Disclaimer